Fig. 2From: Combination high-dose interleukin-2 and nivolumab for programmed cell death-1 refractory metastatic melanoma: a case seriesAxial computed tomography scan of chest for patient 2 before treatment (left) and axial computed tomography scan of patient 2’s chest after treatment with radiation, anti-PD-1, and high-dose IL-2 (right), demonstrating substantial reduction in tumor volumeBack to article page